Depression

Although findings indicate a relationship between vitamin D and mood disorders, further research is needed to clarify efficacy of specific vitamin D levels, as well as supplement dose and form.

SSRI treatment for postnatal depression brought long-term benefits for mothers and their offspring in the following years after childbirth, study findings showed.

KET01 could successfully treat treatment-resistant depression while limiting adverse effects in the home environment, according to the study.

Researchers sought to find a remedy for the development of treatment-resistant depression in patients whose antidepressant treatment has fluctuated in efficacy.

The daily oral formulation of ketamine, KET01, has the potential to greatly improve the standard treatment practices for treatment-resistant depression, according to investigators.

The study implemented a novel workflow for ambulatory care pharmacists to execute pharmacist-administered depression screenings.

A variety of comorbid mood disorders often accompany this condition, including OCD and PTSD.

Though an association was found between depression and anxiety and lung cancers, there were no connections found to overall, breast, prostate, colorectal, and alcohol-related cancers.

However, the FDA said an application for zuranolone to treat major depressive disorder did not provide substantial evidence of efficacy.

Pharmacists working with patients with mental health conditions are able to optimize medication use and improve adherence.

Major pharmacogenomics organizations continue to recognize the potential relevance of pharmacogenomics for psychiatric medication management, mainly due to its effects on pharmacokinetics.

Generic ketamine could cost as little as $5, which is significantly lower than the $800 per dose for the currently available S-ketamine nasal spray.

Further research and regulatory changes are needed, but psychedelic medicines may be able to treat or even cure mental illness in the future.

The benefits of the survey can stretch beyond assessing the parental acceptability of mental health screenings in children and can suggest areas of optimization in providing these screenings more widely and effectively in the future.

Employees who did frequently use AI systems were more than likely to offer help to fellow employees, though it could have been a response to their loneliness.

Several workplace risk factors, including safety concerns going unaddressed, predicted suicidal thoughts.

Depression can affect the trajectory of treatment and associated outcomes.

Pharmacogenomic testing in combination with therapeutic drug monitoring can be a cost effective and efficient way to advance psychiatric drug therapy.

The steroid could be more effective for veterans with post-traumatic stress disorder who do not have a history of traumatic brain injury.

Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.

Common chronic pain conditions included in the analysis were fibromyalgia, neuropathic pain, and musculoskeletal pain.

Health care professionals should educate patients that it is possible to effectively manage pain without opioids.

Based on the study results, investigators concluded that there is justification for a randomized clinical trial.

The risk is particularly high in the first 2 years after an HIV diagnosis.

Pharmacists are cited as one of the most stressed professions and a creative habit can help to improve focus, enhance productivity, and reduce stress.

Investigators suggest that sleep interventions may help to reduce the risk of self-harm in female adolescents with depression and anxiety.

The COVID-19 pandemic marginally affected the negative mental health of women more than men, according to a new study.

Persistently pursuing valued goals and adjusting those goals in response to setbacks or obstacles may help explain how some individuals with chronic pain maintain their mental wellbeing.

Pharmacy programs are implementing new practices into their curriculum and research is being focused on mental health care.

The study clarifies why serotonin-based therapeutics, such as selective serotonin reuptake inhibitors, do not promote neuroplasticity in the same ways as psychedelics and other psychoplastogenic therapeutics.